Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcutis Biotherapeutics Inc.

13.73
-0.1600-1.15%
Post-market: 14.010.2800+2.04%19:41 EDT
Volume:2.99M
Turnover:41.89M
Market Cap:1.64B
PE:-13.20
High:14.42
Open:14.25
Low:13.70
Close:13.89
Loading ...

Director Patrick J. Heron Reports Acquisition of Common Shares in Arcutis Biotherapeutics Inc

Reuters
·
16 May

Arcutis announces publication of Genital Psoriasis Wellness Consortium statement

TIPRANKS
·
15 May

Buy Rating for Arcutis Biotherapeutics: Long-term Growth Potential and Upcoming Catalysts

TIPRANKS
·
12 May

Officer Patrick Burnett Reports Disposal of Arcutis Biotherapeutics Inc. Common Shares

Reuters
·
10 May

Arcutis Biotherapeutics Reports Strong Q1 Earnings Growth

TIPRANKS
·
08 May

Arcutis Biotherapeutics Files Initial Ownership Statement for SVP CFO Latha Vairavan

Reuters
·
08 May

Arcutis Biotherapeutics Inc. Releases Transcript of Q1 2025 Earnings Conference Call

Reuters
·
08 May

Arcutis Biotherapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
07 May

Stock Track | Arcutis Biotherapeutics Plunges 8.38% After Hours on Q1 Operating Loss and High Expenses

Stock Track
·
07 May

Arcutis Biotherapeutics Q1 EPS $(0.20) Beats $(0.21) Estimate, Sales $65.85M Beat $62.25M Estimate

Benzinga
·
07 May

Stock Track | Arcutis Biotherapeutics Plummets 6.75% as Q1 Operating Income Misses Estimates

Stock Track
·
07 May

Stock Track | Arcutis Biotherapeutics Plummets 6.75% as Q1 Operating Loss Exceeds Estimates

Stock Track
·
07 May

Arcutis Biotherapeutics Inc - Pdufa Action Date for Zoryve Foam Set for May 22, 2025

THOMSON REUTERS
·
07 May

Arcutis Biotherapeutics Q1 Operating Income USD -24.529 Million VS. Ibes Estimate USD -23.9 Million

THOMSON REUTERS
·
07 May

Top Executives Cash Out on Arcutis Biotherapeutics Stock!

TIPRANKS
·
06 May

Director Howard G. Welgus Reports Disposal of Common Shares in Arcutis Biotherapeutics Inc

Reuters
·
06 May

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
03 May

Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
03 May

Qiagen (QGEN) Reports Next Week: Wall Street Expects Earnings Growth

Zacks
·
30 Apr

Arcutis Biotherapeutics, Inc. (ARQT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Zacks
·
29 Apr